HOWE & RUSLING INC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 262 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
HOWE & RUSLING INC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$1,0000.0%54
-48.1%
0.00%
Q2 2022$1,0000.0%104
+76.3%
0.00%
Q1 2022$1,0000.0%590.0%0.00%
Q4 2021$1,000
-50.0%
59
-39.8%
0.00%
Q3 2021$2,0000.0%98
+50.8%
0.00%
Q2 2021$2,0000.0%650.0%0.00%
Q1 2021$2,000
-99.2%
65
-98.6%
0.00%
-100.0%
Q4 2020$253,000
+29.7%
4,7300.0%0.04%
+15.2%
Q3 2020$195,000
-14.8%
4,7300.0%0.03%
-21.4%
Q2 2020$229,000
+14.5%
4,7300.0%0.04%
-2.3%
Q1 2020$200,000
+65.3%
4,730
+67.1%
0.04%
+115.0%
Q4 2019$121,000
+18.6%
2,8300.0%0.02%
+11.1%
Q3 2019$102,000
+34.2%
2,8300.0%0.02%
+38.5%
Q2 2019$76,0000.0%2,8300.0%0.01%0.0%
Q1 2019$76,000
+65.2%
2,8300.0%0.01%
+30.0%
Q4 2018$46,000
-22.0%
2,8300.0%0.01%0.0%
Q3 2018$59,000
+37.2%
2,8300.0%0.01%
+25.0%
Q2 2018$43,000
-32.8%
2,8300.0%0.01%
-33.3%
Q1 2018$64,000
-24.7%
2,8300.0%0.01%
-20.0%
Q4 2017$85,000
-20.6%
2,8300.0%0.02%
-25.0%
Q3 2017$107,000
+35.4%
2,8300.0%0.02%
+25.0%
Q2 2017$79,0002,8300.02%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders